HBP.TO · Helix BioPharma Corp.
Canada · RS rating 3 · As of 2026-10-14
| Price | 0.92 CAD |
|---|---|
| 1-day change | -4.2% |
| RS rating (overall / 1M / 3M / 12M) | 3 / 3 / 6 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 3 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (54) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.5% |
| Market cap (USD) | $49.4M |